Annals of Surgical Oncology

, Volume 25, Issue 5, pp 1322–1328 | Cite as

Internal Mammary Lymph Node Biopsy During Free-Flap Breast Reconstruction: Optimizing Adjuvant Breast Cancer Treatment Through Comprehensive Staging

  • Oscar Ochoa
  • Vitali Azouz
  • Alfredo Santillan
  • Steven Pisano
  • Minas Chrysopoulo
  • Peter Ledoux
  • Gary Arishita
  • Norma Ketchum
  • Joel E. Michalek
  • Chet Nastala
Breast Oncology

Abstract

Background

Accurate breast cancer staging is essential for optimal management of adjuvant therapies. While breast lymphatic drainage involves both axillary and internal mammary (IM) lymph node (LN) basins, IM LN sampling is not routinely advocated. The current study analyzes the incidence of IM LN metastases sampled during free flap breast reconstruction and subsequent changes in adjuvant treatment.

Methods

A retrospective analysis of patients with positive IM LN biopsies during free flap breast reconstruction was performed. Pre-reconstruction surgical and adjuvant therapies as well as staging and prognostic data were recorded. Change in adjuvant therapies based solely on IM LN positivity was determined.

Results

IM LN metastases were found on 28 (1.3%) out of 2057 patients and comprised the study population. Mean age was 49 years with pre-reconstruction chemotherapy or radiation administered in 50 or 54% of cases, respectively. Five (18%) patients had previously undergone lumpectomy with axillary sampling. Mean tumor size was 3.1 cm with tumor location evenly distributed among all four quadrants. Ten (36%) patients had isolated IM LN metastases Patients with both axillary and IM disease had larger lesions, increased prevalence of pre-reconstruction chemotherapy and radiation. Based exclusively on positive IM LN disease, 17 (63%) patients had a change in adjuvant therapy.

Conclusion

Despite the low incidence of IM LN metastases, IM LN biopsy during free flap breast reconstruction is recommended. In 36% of cases, nodal metastases were isolated to the IM nodes. Identification of IM metastases influenced adjuvant therapies in a majority of cases.

Notes

Disclosures

There are no conflicts of interest.

References

  1. 1.
    Jansen L, Doting MH, Rutgers EJ, et al. Clinical relevance of sentinel lymph nodes outside the axilla in patients with breast cancer. Br J Surg. 2000;87:920–25.CrossRefPubMedGoogle Scholar
  2. 2.
    Paredes P, Vidal-Sicart S, Zanon G, et al. Clinical relevance of sentinel lymph nodes in the internal mammary chain in breast cancer patients. Eur J Nucl Med Mol Imaging. 2005;32:1283–287.CrossRefPubMedGoogle Scholar
  3. 3.
    Madsen E, Gobardhan P, Bongers V, et al. The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer. Ann Surg Oncol. 2007;14:1486–492.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Caudle AS, Yi M, Hoffman KE, et al. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients. Ann Surg Oncol. 2014;21:60–65.CrossRefPubMedGoogle Scholar
  5. 5.
    Bourre JC, Payan R, Collomb D, et al. Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation? Eur J Nucl Med Mol Imaging.  https://doi.org/10.1007/s00259-008-1034-4.PubMedGoogle Scholar
  6. 6.
    Estourgie SH, Tanis PJ, Nieweg OE, et al. should the hunt for internal mammary chain sentinel nodes begin? An evaluation of 150 breast cancer patients. Ann Surg Oncol. 2003;10:935–41.CrossRefPubMedGoogle Scholar
  7. 7.
    Van Rijk MC, Tanis PJ, Nieweg OE, et al. Clinical implications of sentinel nodes outside the axilla and internal mammary chain in patients with breast cancer. J Surg Oncol. 2006; 94:281–86.CrossRefPubMedGoogle Scholar
  8. 8.
    Chen RC, Lin NU, Golshan M, et al. Internal mammary nodes in breast cancer: diagnosis and implications for patient management: a systematic review. J Clin Oncol. 2008;26:4981–989.CrossRefPubMedGoogle Scholar
  9. 9.
    Johnson N, Soot I, Nelson J, et al. Sentinel node biopsy and internal mammary lymphatic mapping in breast cancer. Ann J Surg. 2000;179:386–88.CrossRefGoogle Scholar
  10. 10.
    Veronesi U, Cascinelli N, Greco M, et al. Prognosis of breast cancer after mastectomy and dissection of internal mammary nodes. Ann Surg. 1985;202:702–07.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Heuts EM, van der Ent PW, Hulsewe KW, et al. Results of tailored treatment for breast cancer patients with internal mammary lymph node metastases. Breast. 2009;18:254–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Postma EL, van Wieringen S, Hobbelink MG, et al. Sentinel lymph node biopsy of the internal mammary chain in breast cancer. Breast Cancer Res Treat. 2012;134:735–41.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Edge S, Byrd D, Compton C, et al (eds). AJCC Cancer Staging Manual. 7th ed. Springer, New York, 2010.Google Scholar
  14. 14.
    Veronesi U, Cascinelli N, Bufalino R, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 1983;198:681–84.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Olson RA, Woods R, Speers C, et al. Does the intent to irradiate the internal mammary nodes impact survival in women with breast cancer? A population-based analysis in British Columbia. Int J Radiat Oncol Biol Phys. 2012;83:35.CrossRefGoogle Scholar
  16. 16.
    Fowble B, Hanlon A, Freedman G, et al. Internal mammary node irradiation neither decreases distant metastases nor improves survival in stage i and ii breast cancer. Int J Radiat Oncol Biol Phys. 2000;47:883.CrossRefPubMedGoogle Scholar
  17. 17.
    Cody HS III, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol. 1995;2:32.CrossRefPubMedGoogle Scholar
  18. 18.
    Grant AL, Lutz KH, Temple-Oberle CF, et al. Incidental internal mammary nodes during recipient vessel dissection in breast reconstruction: are they significant? Plast Reconstr Surg Glob Open. 2014;2:e276–80.CrossRefPubMedGoogle Scholar
  19. 19.
    Leidenius MH, Krogerus LA, Toivonen TS, et al. The clinical value of parasternal sentinel node biopsy in breast cancer. Ann Surg Oncol. 2006;13:321–26.CrossRefPubMedGoogle Scholar
  20. 20.
    Arnez ZM, Snoj M. Sampling of internal mammary chain lymph nodes during breast reconstruction from the abdomen. Tumori. 2005;91:415.PubMedGoogle Scholar
  21. 21.
    Yu JT, Provenzano E, Forouhi P, et al. An evaluation of incidental metastases to internal mammary lymph nodes detected during microvascular abdominal free-flap breast reconstruction. J Plast Reconstr Aesthet Surg. 2011;64:716.CrossRefPubMedGoogle Scholar
  22. 22.
    Knight MA, Nguyen DT, Kobayashi MR, et al. Incidental positive internal mammary lymph nodes: a multiple international institutional investigation. J Reconstr Microsurg. 2008;24:197.CrossRefPubMedGoogle Scholar
  23. 23.
    Hofer SO, Rakhorst HA, Mureau MA, et al. Pathological internal mammary lymph nodes in secondary and tertiary deep inferior epigastric perforator flap breast reconstruction. Ann Plast Surg. 2005; 55:583.CrossRefPubMedGoogle Scholar
  24. 24.
    Madsen EV, Aalders KC, Gobardhan PD, van Oort PM, et al. Prognostic significance of tumor-positive internal mammary sentinel lymph nodes in breast cancer: a multicenter cohort study. Ann Surg Oncol. 2015;22:4254–262.CrossRefPubMedGoogle Scholar
  25. 25.
    Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer. 1977;39:533–38.CrossRefPubMedGoogle Scholar
  26. 26.
    Sugg SL, Ferguson DJ, Posner MC, et al. Should internal mammary nodes be sampled in the sentinel lymph node era? Ann Surg Oncol. 2000;7:188–92.CrossRefPubMedGoogle Scholar
  27. 27.
    Dellapasqua S, Bagnardi V, Balduzzi A, et al. Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastases. Clin Breast Cancer. 2014;14:53–60.CrossRefPubMedGoogle Scholar
  28. 28.
    Estourgie SH, Nieweg OE, Valdés Olmos RA, et al. Lymphatic drainage patterns from the breast. Ann Surg. 2004;239:232–37.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    van der Ent FW, Kengen RA, van der Pol HA, et al. Halsted revisted: internal mammary sentinel lymph node biopsy in breast cancer. Ann Surg. 2001;234:79–84.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Schaverien MV, Purdie CA, Munnoch DA. Clinical value of internal mammary lymph node metastases found incidentally during free-flap recipient vessel exposure. Eur J Surg Oncol. 2013;39:608–12.CrossRefPubMedGoogle Scholar
  31. 31.
    Colleoni M, Zahrieh D, Gelber RD, et al. Site of primary tumor has a prognostic role in operable breast cancer: the International Breast Cancer Study Group experience. J Clin Oncol. 2005;23:1390.CrossRefPubMedGoogle Scholar
  32. 32.
    Farrus B, Vidal-Sicart S, Velasco M, et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys. 2004;3:715–21.CrossRefGoogle Scholar
  33. 33.
    Tanis P, Nieweg O, Valdes Olmos R, et al. Impact of non-axillary sentinel node biopsy on staging and treatment of breast cancer patients. Br J Cancer. 2002;87:705–10.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Heuts E, van der Ent F, von Meyenfeldt M, et al. Internal mammary lymph drainage and sentinel node biopsy in breast cancer. a study of 1008 patients. Eur J Surg Oncol. 2009;35:252–57.Google Scholar
  35. 35.
    Poortmans PM, Collette S, Kirkove C, et al. Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med. 2015;373:317–27.CrossRefPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  • Oscar Ochoa
    • 1
  • Vitali Azouz
    • 2
  • Alfredo Santillan
    • 3
  • Steven Pisano
    • 1
  • Minas Chrysopoulo
    • 1
  • Peter Ledoux
    • 1
  • Gary Arishita
    • 1
  • Norma Ketchum
    • 4
  • Joel E. Michalek
    • 4
  • Chet Nastala
    • 1
  1. 1.Plastic Reconstructive and Microsurgical Associates (PRMA)San AntonioUSA
  2. 2.Summa HealthAkronUSA
  3. 3.Texas OncologySan AntonioUSA
  4. 4.UT HealthSan AntonioUSA

Personalised recommendations